After receiving her MD from Taishan Medical College and MS in Clinical Pharmacology from Fudan University, Dr. An joined Ruijin Hospital for 2 years as a clinical pharmacist and research scientist. Then she pursued a further study and got her PhD degree in Pharmaceutical Sciences from SUNY at Buffalo. After graduation, she joined the R&D group of Abbott (currently known as AbbVie), where she gained extensive hands on experience in clinical drug development, PK/PD modeling and simulation. Prior to joining University of Iowa, Dr. An has worked at University of Florida as an Assistant Professor for one and half years. Her current research interests include building mechanism-based pharmacokinetic and pharmacodynamic modeling of small molecules and large molecules; model-informed drug development (such as antiparasitic drugs and novel HSD-1 inhibitors) and model-informed clinical care (such as antibiotics); population pharmacokinetic modeling of drugs in special populations (such as infants, critically ill patients, and surgical patients); as well as quantitative systems pharmacology (QSP).

Dr. An is an editor of Journal of Pharmaceutical Sciences, and she serves as an editorial board member of Journal of Clinical Pharmacology, The AAPS Journal, and Journal of Pharmacokinetics and Pharmacodynamics. Dr. An has been in the pharmaceutical sciences field for 18 years and has published 96 peer-reviewed articles (as of Dec 2024) in various top journals in the field. She wrote a single author pharmacokinetic textbook, entitled “Essentials in Clinical Pharmacokinetics: Concepts, Dose Optimization, and Biologics”, which was released in May 2024 and is available at Amazon (https://www.amazon.com/Essentials-Clinical-Pharmacokinetics-Optimization-Biologics/dp/1964623006).